A1 Refereed original research article in a scientific journal

Money for nothing? Risks in biopharmaceutical companies from the perspective of public financiers




AuthorsLaura Heinonen, Birgitta Sandberg

PublisherSpringer

Publication year2008

JournalJournal of Commercial Biotechnology

Volume14

First page 287

Last page298

Number of pages12

Web address https://link.springer.com/article/10.1057/jcb.2008.25




Last updated on 2024-26-11 at 15:55